Strategic recommendations from the STARS project to foster academic drug development

Viktoriia Starokozhko et al. Nat Rev Drug Discov. 2023 Apr.

. 2023 Apr;22(4):251-252.

doi: 10.1038/d41573-023-00021-z.

No abstract available

References

1. de Wilde, S., Guchelaar, H.J., Zandvliet, M.L. & Meij., P. Clinical development of gene- and cell-based therapies: overview of the European landscape. Mol. Ther. Methods Clin. Dev. 3, 16073 (2016). - PubMed - DOI - PMC
1. Kinch, M.S., Horn, C., Kraft, Z. & Schwartz, T. Rising academic contributions to drug development: evidence of vigor or trauma? ACS Pharmacol. Transl. Sci. 3, 1427−1429 (2020). - PubMed - DOI - PMC
1. Gilliland, C. T., et al. Putting translational science on to a global stage. Nat. Rev. Drug Discov. 15, 217–218 (2016). - PubMed - DOI - PMC
1. Starokozhko, V. et al. STARS consortium. Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap. Drug Discov. Today 26, 283–288 (2021). - PubMed - DOI
1. Kallio, M. J. et al. Translating academic drug discovery into clinical development: a survey of the awareness of regulatory support and requirements among stakeholders in Europe. Clin. Pharmacol. Ther. 113, 349–359 (2023). - PubMed - DOI